Inventor · disambiguated record
Thomas Huber
Also filed as: HUBER THOMAS · HUBER THOMAS L
27 granted patents·21 pending applications·280 citations·filing 1975–2025
96Inventor score
Top patents by PatentIndex Score
48 records- 0198US10981990B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2020·Granted Apr 20, 2021·11 cites·30 claims
- 0298US9605070B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2015·Granted Mar 28, 2017·67 cites·85 claims
- 0397US9777061B2Treatment of cancer using a CD33 chimeric antigen receptorNOVARTIS AG·Filed 2015·Granted Oct 3, 2017·85 cites·24 claims
- 0495US11155620B2Method of detecting TIM-3 using antibody molecules to TIM-3NOVARTIS AG·Filed 2019·Granted Oct 26, 2021·6 cites·20 claims
- 0593US10472419B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Nov 12, 2019·12 cites·57 claims
- 0693US9884913B2Antibody molecules to TIM-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Feb 6, 2018·12 cites·30 claims
- 0793US9193788B2Anti-IL-17A antibodies and their usesDI PADOVA FRANCO E·Filed 2014·Granted Nov 24, 2015·17 cites·20 claims
- 0892US9789203B2cKIT antibody drug conjugatesABRAMS TINYA·Filed 2014·Granted Oct 17, 2017·11 cites·31 claims
- 0990US2025145703A1Anti-il-17a antibodies and their use in treating autoimmune and inflammatory disordersNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1089US10786578B2CKIT antibody drug conjugatesNOVARTIS AG·Filed 2015·Granted Sep 29, 2020·4 cites·12 claims
- 1187US10117953B2Antibody drug conjugatesNOVARTIS AG·Filed 2016·Granted Nov 6, 2018·2 cites·15 claims
- 1287US9498543B2Antibody drug conjugatesABRAMS TINYA·Filed 2014·Granted Nov 22, 2016·5 cites·15 claims
- 1385US9938342B2Nucleic acid encoding anti-IL-17A antibodiesNOVARTIS AG·Filed 2017·Granted Apr 10, 2018·3 cites·15 claims
- 1482US10851166B2Treatment of cancer using a CD33 chimeric antigen receptorNOVARTIS AG·Filed 2017·Granted Dec 1, 2020·1 cites·22 claims
- 1582US2025213684A1Combination therapies comprising antibody molecules to tim-3NOVARTIS AG·Filed 2024·Application pending·0 cites
- 1681US9650439B2Anti-IL-17A antibodies and their use in treating autoimmune and inflammatoryDI PADOVA FRANCO E·Filed 2015·Granted May 16, 2017·2 cites·8 claims
- 1779US2025353916A1Treatment of cancer using a cd33 chimeric antigen receptorNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1878US10005836B2Antibody drug conjugatesABRAMS TINYA·Filed 2015·Granted Jun 26, 2018·3 cites·22 claims
- 1978US2022185883A1Method of detecting tim-3 using antibody molecules to tim-3NOVARTIS AG·Filed 2021·Application pending·0 cites
- 2075US2020129632A1Antibody drug conjugatesNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2174US12077580B2Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disordersNOVARTIS AG·Filed 2020·Granted Sep 3, 2024·0 cites·7 claims
- 2270US4112069ATreatment of ruminantsRESEARCH CORP·Filed 1975·Granted Sep 5, 1978·19 cites·19 claims
- 2370US2023052970A1Phosphoglycerate kinase 1 (pgk) promoters and methods of use for expressing chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2470US2022133889A1Combination therapies comprising antibody molecules to tim-3NOVARTIS AG·Filed 2021·Application pending·0 cites
- 2569US12338287B2Treatment of cancer using a CD33 chimeric antigen receptorNOVARTIS AG·Filed 2020·Granted Jun 24, 2025·0 cites·24 claims
- 2669US4172127ATreatment of ruminantsRESEARCH CORP·Filed 1978·Granted Oct 23, 1979·20 cites·15 claims
- 2768US10683349B2Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disordersNOVARTIS AG·Filed 2018·Granted Jun 16, 2020·0 cites·19 claims
- 2868US2025179447A1Solubilized apyrases, methods and useNOVARTIS AG·Filed 2024·Application pending·0 cites
- 2965US2018125996A1Antibody drug conjugatesNOVARTIS AG·Filed 2017·Application pending·0 cites
- 3064US12325870B2Solubilized apyrases, methods and useNOVARTIS AG·Filed 2019·Granted Jun 10, 2025·0 cites·8 claims
- 3160US11833215B2CKIT antibody drug conjugatesNOVARTIS AG·Filed 2020·Granted Dec 5, 2023·0 cites·17 claims
- 3259US10626172B2Antibody drug conjugatesABRAMS TINYA·Filed 2018·Granted Apr 21, 2020·0 cites·5 claims
- 3359US2015320880A1Antibody drug conjugatesABRAMS TINYA·Filed 2015·Application pending·0 cites
- 3457US2022175988A1Printable ultraviolet-c (uv-c) chamber to decontaminate reusable personal protective equipment (ppe)UNIV ROCKEFELLER·Filed 2021·Application pending·0 cites
- 3556US2018207273A1Combination therapies comprising antibody molecules to tim-3DRANOFF GLENN·Filed 2016·Application pending·0 cites
- 3655US2022090046A1Encapsulated CellsUNIV AUSTRALIAN NATIONAL·Filed 2020·Application pending·0 cites
- 3754US11459390B2Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptorNOVARTIS AG·Filed 2016·Granted Oct 4, 2022·0 cites·21 claims
- 3854US2023235040A1Anti-il-36 antibodies and methods of use thereofALMIRALL SA·Filed 2021·Application pending·0 cites
- 3948US8999320B2Nanoscale bound bilayers, methods of use and productionSAKMAR THOMAS P·Filed 2009·Granted Apr 7, 2015·0 cites·14 claims
- 4047US2006127893A1Modification of human variable domainsEWERT STEFAN·Filed 2002·Application pending·0 cites
- 4145US10167329B2Stabilized insulin-like growth factor polypeptidesFORNARO MARA·Filed 2013·Granted Jan 1, 2019·0 cites·14 claims
- 4240US2020387533A1Systems and methods for structuring metadataZETADATA SYSTEMS INC·Filed 2020·Application pending·0 cites
- 4339US2019194315A1Antibody drug conjugatesABRAMS TINYA·Filed 2016·Application pending·0 cites
- 4438US2014193408A1Soluble proteins for use as therapeuticsHUBER THOMAS·Filed 2012·Application pending·0 cites
- 4537US2017291939A1Antibodies specific for il-17a fused to hyaluronan binding peptide tagsDI PADOVA FRANCO E·Filed 2015·Application pending·0 cites
- 4634US2013011401A1Soluble proteins for use as therapeuticsNOVARTIS AG·Filed 2010·Application pending·0 cites
- 4734US2015250726A1Nanoscale Bound Bilayers, Methods of Use and ProductionUNIV ROCKEFELLER·Filed 2015·Application pending·0 cites
- 4823USD1055702SPharmaceutical product containerPFIZER·Filed 2021·Granted Dec 31, 2024·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Huber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →